The same natural ligand is involved in allorecognition of multiple HLA- B27 subtypes by a single T cell clone: Role of peptide and the MHC molecule in alloreactivity

Journal of Immunology

Volumn 161, Issue 10, 1998, Pages 5481-5490

  Paradela, Alberto ^a   García Peydró, Marina ^a   Vázquez, Jesús ^a   Rognan, Didier ^b   López De Castro, José A ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b ETH ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HLA B27 ANTIGEN; LIGAND;

ALLOIMMUNITY; ANIMAL CELL; ANTIGEN RECOGNITION; ARTICLE; CONTROLLED STUDY; CROSS REACTION; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; IMMUNOGENICITY; LYMPHOCYTE CLONE; MOLECULAR MODEL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION;

ALLELES; ANTIGEN PRESENTATION; BINDING SITES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CLONE CELLS; EPITOPES; HLA-B27 ANTIGEN; HUMANS; LIGANDS; MODELS, MOLECULAR; OLIGOPEPTIDES; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0032533487     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Heath, W. R., K. P. Kane, M. F. Mescher, and L. A. Sherman. 1991. Alloreactive T cells discriminate among a diverse set of endogenous peptides. Proc. Natl. Acad. Sci. USA 88:5101.
2. Rotzschke, O., K. Falk, S. Faath, and H. G. Rammensee. 1991. On the nature of peptides involved in T cell alloreactivity. J. Exp. Med. 174:1059.
3. Crumpacker, D. B., J. Alexander, P. Cresswell, and V. H. Engelhard. 1992. Role of endogenous peptides in murine allogenic cytotoxic T cell responses assessed using transfectants of the antigen-processing mutant 174×CEM T2. J. Immunol. 148:3004.
4. Wang, W., S. Man, P. H. Gulden, D. F. Hunt, and V. H. Engelhard. 1998. Class I-restricted alloreactive cytotoxic T lymphocytes recognize a complex array of specific MHC-associated peptides. J. Immunol. 160:1091.
5. Elliott, T. J., and H. N. Eisen. 1990. Cytotoxic T lymphocytes recognize a reconstituted class I histocompatibility antigen (HLA-A2) as an allogeneic target molecule. Proc. Nat. Acad. SciUSA 87:5213.
6. Villadangos, J A., B. Galocha, and J. A. Lopez de Castro. 1994. Unusual topology of an HLA-B27 allospecific T cell epitope lacking peptide specificity. J. Immunol. 152:2317.
7. Smith, P. A., A. Brunmark, M. R. Jackson, and T. A. Potter. 1997. Peptide-independent recognition by alloreactive cytotoxic T lymphocytes (CTL). J. Exp. Med. 185:1023.
8. + cytotoxic T cell with apparent high affinity. J. Immunol. 158:5797.
9. + cytotoxic T lymphocytes in association with a class I MHC protein. Cell 69:989.
10. b antigen. Cell 79:649.
11. + T cells can recognize unusual, rare, and unique processed peptide/MHC complexes. J. Immunol. 157:4464.
12. Tsomides, T. J., A. Aldovini, R. P. Johnson, B. D. Walker, R. A. Young, and H. N. Eisen. 1994. Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1. J. Exp. Med. 180:1283.
13. - strains. Proc. Natl. Acad. Sci. USA 91:11482.
14. Evavold, B. D., J. Sloan-Lancaster, K. J. Wilson, J. B. Rothbard, and P. M. Allen. 1995. Specific T cell recognition of minimally homologous peptides: evidence for multiple endogenous ligands. Immunity 2:655.
15. Wucherpfennig, K. W. and J. L. Strominger. 1995. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 80:695.
16. Huang, F., E. Hermann, J. Wang, X. K. Cheng, W. C. Tsai, J. Wen, J. G. Kuipers, H. Kellner, B. Ackermann, G. Roth, K. M. Williams, D. K. Yu, and R. B. Raybourne. 1996. A patient-derived cytotoxic T-lymphocyte clone and two peptide-dependent monoclonal antibodies recognize HLA-B27-peptide complexes with low stringency for peptide sequences. Infect. Immun. 64:120.
17. Tallquist, M. D., T. J. Yun, and L. R. Pease. 1996. A single T cell receptor recognizes structurally distinct MHC/peptide complexes with high specificity. J. Exp. Med. 184:1017.
18. Udaka, K., K. H. Wiesmuller, S. Kienle, G. Jung, and P. Walden. 1996. Self-MHC-restricted peptides recognized by an alloreactive T lymphocyte clone. J. Immunol. 157:670.
19. b major histocompatibility complex class I molecule to alloreactive T cells. J. Exp. Med. 182:1739.
20. Lopez, D., R. Garcia Hoyo, and J. A. Lopez de Castro. 1994. Clonal analysis of alloreactive T cell responses against the closely related B*2705 and B*2703 subtypes: implications for HLA-B27 association to spondyloarthropathy. J. Immunol. 152:5557.
21. Garcia, K. C., M. Degano, R. L. Stanfield, A. Brunmark, M. R. Jackson, P. A. Peterson, L. Teyton, and I. A. Wilson. 1996. An αβ T cell receptor structure at 2.5 Å and its orientation in the TCR-MHC complex. Science 274:209.
22. Garboczi, D. N., P. Ghosh, U. Utz, Q. R. Fan, W. E. Biddison, and D. C. Wiley. 1996. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature 384:134.
23. Cerundolo, V., J. Alexander, K. Anderson, C. Lamb, P. Cresswell, A. McMichael, F. Gotch, and A. Townsend. 1990. Presentation of viral antigen controlled by a gene in the major histocompatibility complex. Nature 345:449.
24. Villadangos, J. A., B. Galocha, F. Garcia, J. P. Albar, and J. A. Lopez de Castro. 1995. Modulation of peptide binding by HLA-B27 polymorphism in pockets A and B. and peptide specificity of B*2703. Eur. J. Immunol. 25:2370.
25. Galocha, B., J. R. Lamas, J. A. Villadangos, J. P. Albar, and J. A. Lopez de Castro. 1996. Binding of peptides naturally presented by HLA-B27 to the differentially disease-associated B*2704 and B*2706 subtypes, and to mutants mimicking their polymorphism. Tissue Antigens 48:509.
26. Garcia, F., B. Galocha, J. A. Villadangos, J. R. Lamas, J. P. Albar, A. Marina, and J. A. Lopez de Castro. 1997. HLA-B27 (B*270I) specificity for peptides lacking Arg2 is determined by polymorphism outside the B pocket. Tissue Antigens 49: 580.
27. Case, D. A., D. A. Pearlman, J. C. Caldwell, T. E. Cheatman III, W. C. Ross, C. L. Simmerling, T. A. Dardem, A. Mertz, R. V. Stanton, A. L. Cheng, et al. 1997. AMBER5. University of California, San Francisco.
28. Cornell, W. D., P. Cieplak, C. I. Bayly, I. R. Gould, J. R. Merz, D. M. Ferguson, D. M. Spellmeyer, T. Fox, J. W. Caldwell, and P. E. Kollman. 1995. A second generation force field for the simulation of proteins, nucleic acids, and organic molecules. J. Am. Chem. Soc. 117:5179.
29. Madden, D. R., J. C. Gorga, J. L. Strominger, and D. C. Wiley. 1992. The three-dimensional structure of HLA-B27 at 2.1 Å resolution suggests a general mechanism for tight peptide binding to MHC. Cell 70:1035.
30. b. Science 257:919.
31. Madden, D. R., D. N. Garboczi, and D. C Wiley. 1993. The antigenic identity of peptide-MHC complexes: a comparison of the conformations of five viral peptides presented by HLA-A2. Cell 75:693.
32. Smith, K. J., S. W. Reid, D. I. Stuart, A. J. McMichael, E. Y. Jones, and J. I. Bell. 1996. An altered position of the α2 helix of MHC class 1 is revealed by the crystal structure of HLA-B*3501. Immunity 4:203.
33. Rognan, D., L. Scapozza, G. Folkers, and A. Daser. 1995. Rational design of nonnatural peptides as high-affinity ligands for the HLA-B*2705 human leukocyte antigen. Proc. Natl. Acad. Sci. USA 92:753.
34. Rognan, D., S. Krebs, O. Kuonen, J. R. Lamas, and J. A. Lopez de Castro. 1997. Fine specificity of antigen binding to two class I major histocompatibility proteins (B*2705 and B*2703) differing in a single amino acid residue. J. Comput. Aided Mol. Des. 11:463.
35. Garcia, F., D. Rognan, J. R. Lamas, A. Marina, and J. A. Lopez de Castro. 1998. An HLA-B27 polymorphism (B*2710) that is critical for T-cell recognition has limited effects on peptide specificity. Tissue Antigens 58:1.
36. Rotzschke, O., K. Falk, S. Stevanovic, V. Gnau, G. Jung, and H. G. Rammensee. 1994. Dominant aromatic/aliphatic C-terminal anchor in HLA-B*2702 and B*2705 peptide motifs. Immunogenetics 39:74.
37. Fiorillo, M. T., L. Meadows, M. D'Amato, J. Shabanowitz, D. F. Hunt, E. Apella, and R. Sorrentino. 1997. Susceptibility to ankylosing spondylitis correlates with the C-terminal residue of peptides presented by various HLA-B27 subtypes. Eur. J. Immunol. 27:368.
38. Boisgérault, F., V. Tieng, M. C. Stolzenberg, N. Dulphy, I. Khalil, R. Tamouza, D. Charron, and A. Toubert. 1996. Differences in endogenous peptides presented by HLA-B*2705 and B*2703 allelic variants: implications for susceptibility to spondylarthropathies. J. Clin. Invest. 98:2764.
39. Poindexter, N. J., B. Naziruddin, D. W. McCourt, and T. Mohanakumar. 1995. Isolation of a kidney-specific peptide recognized by alloreactive HLA-A3-restricted human CTL. J. Immunol. 154:3880.
40. Henderson, R. A., A. L. Cox, K. Sakaguchi, E. Appella, J. Shabanowitz, D. F. Hunt, and V. H. Engelhard. 1993. Direct identification of an endogenous peptide recognized by multiple HLA-A2.1-specific cytotoxic T cells. Proc. Natl. Acad. Sci. USA 90:10275.
41. Cox, A. L., J. Skipper, Y. Chen, R. A. Henderson, T. L. Darrow, J. Shabanowitz, V. H. Engelhard, D. F. Hunt, and C. L. J. Slingluff. 1994. Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. Science 264:716.
42. Den Haan, J. M., N. E. Sherman, E. Blokland, E. Huczko, F. Koning, J. W. Drijfhout, J. Skipper, J. Shabanowitz, D. F. Hunt, and V. H. Engelhard. 1995. Identification of a graft versus host disease-associated human minor histocompatibility antigen. Science 268:1476.
43. Simmons, W. A., S. G. Summerfield, D. C. Roopenian, C. A. Slaughter, A. R. Zuberi, S. J. Gaskell, R. S. Bordoli, J. Hoyes, C. R. Moomaw, R. A. Colbert, L. Y. W. Leong, G. W. Butcher, R. E. Hammer, and J. D. Taurog. 1997. Novel HY peptide antigens presented by HLA-B27. J. Immunol. 159:2750.
44. Coux, O., K. Tanaka, and A. L. Goldberg. 1996. Structure and functions of the 20S and 26S proteasomes. Annu. Rev. Biochem. 65:801.
45. Valitutti, S., and A. Lanzavecchia. 1997. Serial triggering of TCRs: a basis for the sensitivity and specificity of antigen recognition. Immunol. Today 18:299.
46. Barber, D. F., D. Lopez, and J. A. Lopez de Castro. 1995. Tcell receptor diversity in alloreactive responses against HLA-B27 (B*2705) is limited by multiple-level restrictions in both a and β chains. Eur. J. Immunol. 25:2479.
47. Lopez, D., S. Rojo, V. Calvo, and J. A. Lopez de Castro. 1992. Peptide-presenting similarities among functionally distant HLA-B27 subtypes revealed by allo-reactive T lymphocytes of unusual specificity. J. Immunol. 148:996.
48. Brooks, J. M., R. J. Murray, W. A. Thomas, M. G. Kurilla, and A. B. Rickinson. 1993. Different HLA-B27 subtypes present the same immunodominant Epstein-Barr virus peptide. J. Exp. Med. 178:879.
49. Lamas, J. R., J. M. Brooks, B. Galocha, A. B. Rickinson, and J. A. Lopez de Castro. 1998. Relationship between peptide binding and T cell epitope selection: a study with subtypes of HLA-B27. Int. Immunol. 10:259.
50. Sidney, J., M. F. del Guercio, S. Southwood, V. H. Engelhard, E. Appella, H. G. Rammensee, K. Falk, O. Rotzschke, M. Takiguchi, and R. T. Kubo. 1995. Several HLA alleles share overlapping peptide specificities. J. Immunol. 154:247.
51. Malarkannan, S., S. Goth, D. R. Buchholz, and N. Shastri. 1995. The role of MHC class I molecules in the generation of endogenous peptide/MHC complexes. J. Immunol. 154:585.
52. Benjamin, R., and P. Parham. 1990. Guilt by association: HLA-B27 and anky-losing spondylitis. Immunol. Today 11:137.
53. Breur-Vriesendorp, B. S., A. J. Dekker Saeys, and P. Ivanyi. 1987. Distribution of HLA-B27 subtypes in patients with ankylosing spondylitis: the disease is associated with a common determinant of the various B27 molecules. Ann. Rheum. Dis. 46:353.
54. Lopez-Larrea, C., K. Sujirachato, N. K. Mehra, P. Chiewsilp, D. Isarangkura, U. Kanga, O. Dominguez, E. Coto, M. Pena, F. Setien, and S. Gonzalez-Roces. 1995. HLA-B27 subtypes in Asian patients with ankylosing spondylitis: evidence for new associations. Tissue Antigens 45:169.
55. D'Amato, M., M. T. Fiorillo, C. Carcassi, A. Mathieu, A. Zuccarelli, P. P. Bitti, R. Tosi, and R. Sorrentino. 1995. Relevance of residue 116 of HLA-B27 in determining susceptibility to ankylosing spondylitis. Eur. J. Immunol. 25:3199.
56. Garcia, F., A. Marina, and J. A. Lopez de Castro. 1997. Lack of carboxyl-terminal tyrosine distinguishes the B*2706-bound peptide repertoire from those of B*2704 and other HLA-B27 subtypes associated to ankylosing spondylitis. Tissue Antigens 49:215.
57. Roepstorff, P., and J. Fohlman. 1984. Proposal for a common nomenclature for sequence ions in mass spectra of peptides. Biomed. Mass Spectrom. 11:601.
58. Koradi, R., M. Billeter, and K. Wüthrich. 1996. MOLMOL: a program for display and analysis of macromolecular structures. J. Mol. Graph. 14:51.
59. Nicholls, A., K. A. Sharp, and B. Honig. 1991. Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins 11:281.